Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1233 ARTÍCULOS , VIENDO DEL 511 AL 525

Relevance of Follow-Up in Patients with Core Clinical Criteria for Alzheimer Disease and Normal CSF Biomarkers

Vercruysse O, Paquet C, Gabelle A, Delbeuck X, Blanc F, Wallon D, Dumurgier J, Magnin E, Martinaud O, Jung B, Bousiges O, Lehmann S, Delaby C, Quillard-Murain M, Peoc H K, Laplanche JL, Bouaziz-Amar E, Hannequin D, Sablonniere B, Buee L, Hugon J, Schraen S, Pasquier F, Bombois S, For The E-Plm Group.

Curr Alzheimer Res. 2018;15(7):691-700. doi: 10.2174/1567205015666180110113238.

A Perfect sTORm: The Role of the Mammalian Target of Rapamycin (mTOR) in Cerebrovascular Dysfunction of Alzheimer's Disease: A Mini-Review

Van Skike CE, Galvan V.

Gerontology. 2018;64(3):205-211. doi: 10.1159/000485381. Epub 2018 Jan 11.

Sex differences in Alzheimer's disease

Laws KR, Irvine K, Gale TM.

Curr Opin Psychiatry. 2018 Mar;31(2):133-139. doi: 10.1097/YCO.0000000000000401.

Impact of social relationships on Alzheimer's memory impairment: mechanistic studies

Hsiao YH, Chang CH, Gean PW.

J Biomed Sci. 2018 Jan 11;25(1):3. doi: 10.1186/s12929-018-0404-x.

Serum haptoglobin in Chinese patients with Alzheimer's disease and mild cognitive impairment: A case-control study

Zhu CJ, Jiang GX, Chen JM, Zhou ZM, Cheng Q.

Brain Res Bull. 2018 Mar;137:301-305. doi: 10.1016/j.brainresbull.2018.01.005. Epub 2018 Jan 9.

Alzheimer's disease biomarker-guided diagnostic workflow using the added value of six combined cerebrospinal fluid candidates: Aβ(1-42), total-tau, phosphorylated-tau, NFL, neurogranin, and YKL-40

Hampel H, Toschi N, Baldacci F, Zetterberg H, Blennow K, Kilimann I, Teipel SJ, Cavedo E, Melo Dos Santos A, Epelbaum S, Lamari F, Genthon R, Dubois B, Floris R, Garaci F, Lista S; Alzheimer Precision Medicine Initiative (APMI).

Alzheimers Dement. 2018 Apr;14(4):492-501. doi: 10.1016/j.jalz.2017.11.015. Epub 2018 Jan 9.

Use of multimodality imaging and artificial intelligence for diagnosis and prognosis of early stages of Alzheimer's disease

Liu X, Chen K, Wu T, Weidman D, Lure F, Li J.

Transl Res. 2018 Apr;194:56-67. doi: 10.1016/j.trsl.2018.01.001. Epub 2018 Jan 10.

A systematic review of the diagnostic accuracy of automated tests for cognitive impairment

Aslam RW, Bates V, Dundar Y, Hounsome J, Richardson M, Krishan A, Dickson R, Boland A, Fisher J, Robinson L, Sikdar S.

Int J Geriatr Psychiatry. 2018 Apr;33(4):561-575. doi: 10.1002/gps.4852. Epub 2018 Jan 22.

Association of β-Amyloid and Apolipoprotein E ε4 With Memory Decline in Preclinical Alzheimer Disease

Lim YY, Kalinowski P, Pietrzak RH, Laws SM, Burnham SC, Ames D, Villemagne VL, Fowler CJ, Rainey-Smith SR, Martins RN, Rowe CC, Masters CL, Maruff PT.

JAMA Neurol. 2018 Apr 1;75(4):488-494. doi: 10.1001/jamaneurol.2017.4325.

Systemic inflammation as a predictor of brain aging: Contributions of physical activity, metabolic risk, and genetic risk

Corlier F, Hafzalla G, Faskowitz J, Kuller LH, Becker JT, Lopez OL, Thompson PM, Braskie MN.

Neuroimage. 2018 May 15;172:118-129. doi: 10.1016/j.neuroimage.2017.12.027. Epub 2018 Jan 28.

Auditory Event-related Potentials in Mild Cognitive Impairment and Alzheimer's Disease

Morrison C, Rabipour S, Knoefel F, Sheppard C, Taler V.

Curr Alzheimer Res. 2018;15(8):702-715. doi: 10.2174/1567205015666180123123209.

The neuronal Shc adaptor in Alzheimer's Disease

Triaca V, Coccurello R, Giacovazzo G.

Aging (Albany NY). 2018 Jan 22;10(1):5-6. doi: 10.18632/aging.101368.

High blood pressure, Alzheimer disease and antihypertensive treatment

Marfany A, Sierra C, Camafort M, Doménech M, Coca A.

Panminerva Med. 2018 Mar;60(1):8-16. doi: 10.23736/S0031-0808.18.03360-8. Epub 2018 Jan 25.

A novel language-neutral Visual Cognitive Assessment Test (VCAT): validation in four Southeast Asian countries

Lim L, Ng TP, Ong AP, Tan MP, Cenina AR, Gao Q, Ng A, Kandiah N.

Alzheimers Res Ther. 2018 Jan 22;10(1):6. doi: 10.1186/s13195-017-0333-z.

Is It Time to Consider Obstructive Sleep Apnea Syndrome a Risk Factor for Alzheimer's Disease?

Liguori C, Placidi F.

Am J Respir Crit Care Med. 2018 Apr 1;197(7):855-856. doi: 10.1164/rccm.201710-2105ED.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias